Mary T Scott
6PUBLICATIONS
38CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jun 12, 2024
Nutrient-sensitizing drug repurposing screen identifies lomerizine as a mitochondrial metabolism inhibitor of chronic myeloid leukemia.Ahmed Khalaf, Lucie de Beauchamp, Eric Kalkman
|Feb 05, 2024
Leukaemia exposure alters the transcriptional profile and function of BCR::ABL1 negative macrophages in the bone marrow niche.Amy Dawson, Martha M Zarou, Bodhayan Prasad
|Jan 21, 2024
Activating p53 abolishes self-renewal of quiescent leukaemic stem cells in residual CML disease.Mary T Scott, Wei Liu, Rebecca Mitchell
|Aug 17, 2023
Pyruvate anaplerosis is a targetable vulnerability in persistent leukaemic stem cells.Kevin M Rattigan, Zuzana Brabcova, Daniele Sarnello
|Sep 29, 2021
ULK1 inhibition promotes oxidative stress-induced differentiation and sensitizes leukemic stem cells to targeted therapy.Angela Ianniciello, Martha M Zarou, Kevin M Rattigan
|Feb 14, 2018
<i>hsa-mir183/EGR1</i>-mediated regulation of E2F1 is required for CML stem/progenitor cell survival.Francesca Pellicano, Laura Park, Lisa E M Hopcroft
Pageof 1
Frequent Collaborators
5 joint publications
Karen Dunn
5 joint publications
Mhairi Copland
5 joint publications
G Vignir Helgason
3 joint publications
Martha M Zarou
3 joint publications
Eric R Kalkman
3 joint publications
Alison M Michie
3 joint publications
David Vetrie
2 joint publications
Cassie J Clarke
2 joint publications
Kevin Rattigan
2 joint publications
Lisa E M Hopcroft
